Skip to main content

Table 3 Myogenic purity of myoblasts in culture

From: Targeting myomiRs by tocotrienol-rich fraction to promote myoblast differentiation

Groups

Myogenicity (%)

Young control (PD14)

95.23 ± 2.14

Senescent control (PD21)

92.84 ± 0.80

Young TRF-treated

96.35 ± 1.87

Senescent TRF-treated

94.22 ± 0.42